Lipodystrophy syndromes.
Lipodystrophy syndromes comprise a group of rare, heterogeneous disorders characterized by progressive loss of fat tissue, mainly from subcutaneous compartment and occasionally affecting visceral fat. Lipoatrophy may be partial, localized, or generalized. The latter cases are usually accompanied by metabolic-related disorders, including insulin resistance, diabetes mellitus, hyperlipemia, progressive hepatic disease and anabolic state. Treatment for lipodystrophy has increased interest in recent years because a new lipoatrophic population-patients who have HIV-associated lipodystrophy--is much more numerous than the whole number of patients affected by classic lipodystrophy entities.
Herranz
Pedro
P
Department of Dermatology, La Paz University Hospital, Universidad Autónoma, Paseo Castellana 261, 28046 Madrid, Spain. peherranz@mi.madritel.es
de Lucas
Raul
R
Pérez-España
Luis
L
Mayor
Matias
M
D000273:Adipose Tissue / Q000473:pathology*; D003937:Diagnosis, Differential; D006801:Humans; D008060:Lipodystrophy / Q000145:classification / Q000175:diagnosis*; D013577:Syndrome
EMBO Mol Med. 2009 Aug;1(5):280-7
20049731
Diabetes. 2005 Jul;54(7):1994-2002
15983199
Ther Clin Risk Manag. 2015 Sep 16;11:1391-400
26396524
J Clin Endocrinol Metab. 2012 Mar;97(3):785-92
22170723
Can J Cardiol. 2014 Dec;30(12):1649-54
25475467
J Clin Invest. 2006 Mar;116(3):581-9
16511590
J Clin Endocrinol Metab. 2002 May;87(5):2395
11994394
N Engl J Med. 2011 Feb 24;364(8):740-8
21345103
J Clin Endocrinol Metab. 2003 Jun;88(6):2821-4
12788894
N Engl J Med. 2002 Feb 21;346(8):570-8
11856796
Hum Mol Genet. 2003 Aug 15;12(16):1995-2001
12913070
N Engl J Med. 2004 Mar 18;350(12):1220-34
15028826
J Clin Endocrinol Metab. 2008 Apr;93(4):1129-34
18211975
Leuk Lymphoma. 2016;57(1):45-50
25864863
J Clin Endocrinol Metab. 1983 Sep;57(3):517-23
6348062
Nat Genet. 2002 May;31(1):21-3
11967537
J Clin Endocrinol Metab. 2009 Dec;94(12):4971-83
19875478
J Clin Endocrinol Metab. 2003 Oct;88(10):4840-7
14557463
Nat Genet. 2001 Aug;28(4):365-70
11479539
Diabetologia. 2010 Jan;53(1):27-35
19727665
Medicine (Baltimore). 2004 Jan;83(1):18-34
14747765
Biochemistry. 2003 Dec 23;42(50):14711-9
14674745
N Engl J Med. 2008 Feb 7;358(6):592-604
18256394
J Clin Endocrinol Metab. 2000 May;85(5):1776-82
10843151
Nat Genet. 2000 Feb;24(2):153-6
10655060
N Engl J Med. 2005 Jan 6;352(1):48-62
15635112
Am J Med Genet A. 2014 May;164A(5):1341-5
24665001
Am J Hum Genet. 2000 Apr;66(4):1192-8
10739751
J Clin Endocrinol Metab. 2002 Jan;87(1):408-11
11788685
J Clin Endocrinol Metab. 2002 Nov;87(11):4845-56
12414837
J Clin Endocrinol Metab. 2009 Jan;94(1):10-6
18854390
J Clin Endocrinol Metab. 2010 Mar;95(3):1463-8
20097706
Hum Mol Genet. 2000 Jan 1;9(1):109-12
10587585
Science. 2004 May 28;304(5675):1325-8
15166380
Am J Med. 2000 Feb;108(2):143-52
11126308
Am J Hum Genet. 2010 Dec 10;87(6):866-72
21129723
J Med Genet. 1986 Apr;23(2):120-7
3712389
J Med Genet. 2002 Oct;39(10):722-33
12362029
J Clin Endocrinol Metab. 2010 Oct;95(10):E192-7
20631028
J Clin Endocrinol Metab. 2011 Nov;96(11):3313-25
21865368
Endocr Pract. 2013 Jan-Feb;19(1):107-16
23435042
J Clin Endocrinol Metab. 1999 Jan;84(1):170-4
9920078
N Engl J Med. 2014 Jun 12;370(24):2307-2315
24848981
PLoS Genet. 2010 Mar 12;6(3):e1000874
20300641
Biochem Biophys Res Commun. 2008 Sep 19;374(2):365-8
18639527
Medicine (Baltimore). 2003 Mar;82(2):129-46
12640189
Nat Genet. 2013 Aug;45(8):947-50
23770608
J Clin Invest. 2009 Sep;119(9):2623-33
19726876
Am J Hum Genet. 2002 Aug;71(2):426-31
12075506
Am J Hum Genet. 2013 Jul 11;93(1):141-9
23810378
J Clin Endocrinol Metab. 2010 Sep;95(9):E58-63
20534754
Am J Med Genet A. 2010 Sep;152A(9):2245-53
20684003
Am J Med Genet A. 2015 Aug;167A(8):1796-806
25898808
Clin Genet. 2010 Jul;78(1):66-73
20041886
Am J Med Genet A. 2010 Nov;152A(11):2749-55
20979188
Metabolism. 2007 Apr;56(4):508-16
17379009